What's breaking now, across thousands of outlets.
Lisraya’s clearance marks the first approval of a drug the Roivant subsidiary licensed from Pfizer and has since positioned against multiple rare inflammatory conditions.
We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.
This is one outlet's version. Read the fullest account.
Publish the PM2.5 reading alongside the air pollutant index, which only says the air is unhealthy without saying what people are inhaling. Warn vulnerable groups ahead of time.
Publish the PM2.5 reading alongside the air pollutant index, which only says the air is unhealthy without saying what people are inhaling. Warn vulnerable groups ahead of time.
NORTH BETHESDA, Md. — Pinion Immunotherapeutics has published preclinical data supporting ARV-2001, its lead RNA immunotherapy, in the peer-reviewed journal Vaccines.
RFK Jr.'s vaccine questions in Samoa, former Stanford president rebuts fraud allegations, and more health news from Morning Rounds
DALAT (Aug 28): Sarawak is expected to become an ageing state by 2028, increasing the need for elderly care services, community support and skilled caregivers, said Dato Sri Fatimah Abdullah.
